Literature DB >> 28012056

Pachymeningitis in granulomatosis with polyangiitis: case series with earlier onset in younger patients and literature review.

Violeta Higuera-Ortiz1, Abraham Reynoso2, Natllely Ruiz1, Rosa Delia Delgado-Hernández2, Gilberto Gómez-Garza3, Luis Felipe Flores-Suárez4.   

Abstract

The objective of this study is to describe the characteristics of patients with pachymeningitis (PM) in granulomatosis with polyangiitis (GPA) from Latin America, including three young patients. This is a retrospective case series. Patients were classified according to the ACR criteria, the 2012 Chapel Hill Consensus Conference Nomenclature and the EMA algorithm. Demographic, clinical, serological, and neuroimaging characteristics are described. Thirteen patients (nine females, four males) were identified. Mean age ± SD of PM diagnosis was 35.5 ± 20.4 years (median 48, range 8-71 years). Mean time ± SD between GPA first symptom and PM diagnosis was 59.8 ± 70.1 months (median 48, range 2-252 months). An important difference between children and adults was the median time elapsed between first GPA symptoms and PM diagnosis (range 2-4 months vs 5-252 months, respectively). Chronic headache was present in all, followed by intracranial hypertension (n = 5), single cranial nerve palsy and orbital mass (n = 4), seizures (n = 3), cavernous sinus syndrome and multiple cranial nerve palsies (n = 2), and meningism and cerebellar syndrome (n = 1 each). At time of PM diagnosis, mean BVAS/WG (Birmingham Vasculitis Activity Score for Wegener's granulomatosis) was 4 ± 2.4 and mean VDI of 2 ± 1.6, mostly due to ENT damage. Gadolinium-enhanced brain MRI showed dural thickening in 12 patients and leptomeningeal enhancement in one. All received a combination of glucocorticoids plus immunosuppressants, rituximab being used favourably in one refractory case. Improvement was observed in 12 patients. Chronic headache should lead to suspect PM. PM predominates in localised GPA. Children may present it earlier in the disease course than adults. Treatment is non-standardised and remains difficult.

Entities:  

Keywords:  Central nervous system; Granulomatosis with polyangiitis; MRI; Pachymeningits; Vasculitis

Mesh:

Substances:

Year:  2016        PMID: 28012056     DOI: 10.1007/s10067-016-3520-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Wegener granulomatosis: MR imaging findings in brain and meninges.

Authors:  J M Murphy; B Gomez-Anson; J H Gillard; N M Antoun; J Cross; J D Elliott; M Lockwood
Journal:  Radiology       Date:  1999-12       Impact factor: 11.105

2.  A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

Authors:  J H Stone; G S Hoffman; P A Merkel; Y I Min; M L Uhlfelder; D B Hellmann; U Specks; N B Allen; J C Davis; R F Spiera; L H Calabrese; F M Wigley; N Maiden; R M Valente; J L Niles; K H Fye; J W McCune; E W St Clair; R A Luqmani
Journal:  Arthritis Rheum       Date:  2001-04

3.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods.

Authors:  D A Bloch; B A Michel; G G Hunder; D J McShane; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; J F Fries; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

4.  Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.

Authors:  A R Exley; P A Bacon; R A Luqmani; G D Kitas; C Gordon; C O Savage; D Adu
Journal:  Arthritis Rheum       Date:  1997-02

5.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

6.  Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature.

Authors:  E Reinhold-Keller; K de Groot; K Holl-Ulrich; A C Arlt; M Heller; A C Feller; W L Gross
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

7.  Clinical features and outcome of pediatric Wegener's granulomatosis.

Authors:  J D Akikusa; R Schneider; E A Harvey; D Hebert; P S Thorner; R M Laxer; E D Silverman
Journal:  Arthritis Rheum       Date:  2007-06-15

8.  Clinical features in 17 paediatric patients with Wegener granulomatosis.

Authors:  Vladimir M Belostotsky; Vanita Shah; Michael J Dillon
Journal:  Pediatr Nephrol       Date:  2002-08-08       Impact factor: 3.714

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

10.  Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature.

Authors:  Audrey De Parisot; Xavier Puéchal; Corinne Langrand; Gerald Raverot; Helder Gil; Laurent Perard; Guillaume Le Guenno; Sabine Berthier; Olivier Tschirret; Jean Paul Eschard; Stephane Vinzio; Loïc Guillevin; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

View more
  5 in total

1.  Lessons of the month: ANCA-associated vasculitis - granulomatosis with polyangiitis: 'the great mimic'.

Authors:  James Hesford; Andrew Rl Medford; Harsha Gunawardena
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

2.  ANCA-Negative Granulomatosis with Polyangiitis Presenting with Hypertrophic Cranial Pachymeningitis, Abducens Nerve Palsy, and Stenosis of the Internal Carotid Artery.

Authors:  Shohei Harabuchi; Nobuyuki Bandoh; Rika Yasukawa; Michihisa Kono; Takashi Goto; Yasuaki Harabuchi; Hidetoshi Ikeda; Hajime Kamada; Hiroshi Nishihara
Journal:  Case Rep Otolaryngol       Date:  2017-11-30

3.  Adolescent PR3-ANCA-positive hypertrophic pachymeningitis: A case report and review of the literature.

Authors:  Kotaro Matsumoto; Mitsuhiro Akiyama; Nobuhiko Kajio; Kotaro Otomo; Kazuko Suzuki; Naoshi Nishina; Kento Kasuya; Naoki Oishi; Kaori Kameyama; Tsutomu Takeuchi
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

Review 4.  Pituitary dysfunction in granulomatosis with polyangiitis.

Authors:  Arturo Vega-Beyhart; Irene Rocío Medina-Rangel; Andrea Hinojosa-Azaola; Milagros Fernández-Barrio; Ana Sofía Vargas-Castro; Lucía García-Inciarte; Alberto Guzmán-Pérez; Tania Raisha Torres-Victoria; Froylán David Martínez-Sánchez; Mireya Citlali Pérez-Guzmán; José Miguel Hinojosa-Amaya; Andrés León-Suárez; Miguel Angel Gómez-Sámano; Francisco Javier Gómez-Pérez; Daniel Cuevas-Ramos
Journal:  Clin Rheumatol       Date:  2019-08-24       Impact factor: 2.980

5.  Construction of an MRI-based decision tree to differentiate autoimmune and autoinflammatory inner ear disease from chronic otitis media with sensorineural hearing loss.

Authors:  Boeun Lee; Yun Jung Bae; Byung Yoon Choi; Young Seok Kim; Jin Hee Han; Hyojin Kim; Byung Se Choi; Jae Hyoung Kim
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.